{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:44:18Z","timestamp":1761540258672},"reference-count":16,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2001,3,22]],"date-time":"2001-03-22T00:00:00Z","timestamp":985219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2001,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Limited data are available regarding optimal treatment with desmopressin (DDAVP) or intermediate\u2010purity FVIII concentrates rich in VWF (CFCs) in patients with von Willebrand disease (VWD) who undergo planned surgery. We undertook a retrospective review over 10 years (1988\u20131997) and identified 27 patients treated with DDAVP for 35 surgical events and 38 patients who received CFCs for 68 elective surgical events. Tranexamic acid was usually added for mucosal surgery. The FVIII:C levels and the severity of surgery were used to determine the frequency and the doses of postoperative treatment. For major surgery the median pre\u2010 and post\u2010operative doses of CFCs were 54 and 43 IU\/kg, respectively, and for minor surgery the median doses varied between 34 and 52 IU\/kg preoperatively and between 23 and 37 IU\/kg postoperatively. The effectiveness of haemostasis was excellent in 32 events (91%) treated with DDAVP and in 56 events (82%) treated with CFCs. It is concluded that patients with VWD do not carry an increased operative risk if appropriate therapy is given. Am. J. Hematol. 66:280\u2013284, 2001. \u00a9 2001 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/ajh.1058","type":"journal-article","created":{"date-parts":[[2002,8,25]],"date-time":"2002-08-25T21:27:27Z","timestamp":1030310847000},"page":"280-284","source":"Crossref","is-referenced-by-count":53,"title":["Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease"],"prefix":"10.1002","volume":"66","author":[{"given":"Ioana C.","family":"Nitu\u2010Whalley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Griffioen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,3,22]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V69.2.454.454"},{"issue":"2","key":"e_1_2_1_3_2","first-page":"1","article-title":"Von Willebrand Working Party Guidelines for the Diagnosis and Management of Von Willebrand Disease","volume":"3","author":"UKHCDO: United Kingdom Haemophilia Centre Directors Organisation","year":"1997","journal-title":"Haemophilia"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91197-7"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.1992.tb01198.x"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.0040s3033.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.0040s3025.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649942"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.440661.x"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215100130373"},{"issue":"4","key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1055\/s-0038-1657727","article-title":"Von Willebrand factor activity detected in a monoclonal antibody\u2010based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use","volume":"78","author":"Murdock PJ","year":"1997","journal-title":"Thromb Haemostasis"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02654.x"},{"key":"e_1_2_1_13_2","first-page":"21","article-title":"Use of high\u2010purity factor VIII concentrate (Hemate P) in von Willebrand's disease","volume":"56","author":"Berntrop E","year":"1989","journal-title":"Vox Sang"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1999.0050s2064.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.2000.00370.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1998.0040s3048.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2516.1997.00073.x"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.1058","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.1058","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T13:30:24Z","timestamp":1700400624000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.1058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3,22]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,4]]}},"alternative-id":["10.1002\/ajh.1058"],"URL":"https:\/\/doi.org\/10.1002\/ajh.1058","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,3,22]]}}}